UNIGE document Scientific Article
previous document  unige:1825  next document
add to browser collection

Increasing GLP-1-induced beta-cell proliferation by silencing the negative regulators of signaling cAMP response element modulator-alpha and DUSP14

Klinger, Sonia
Poussin, Carine
Debril, Marie-Bernard
Dolci, Wanda
Published in Diabetes. 2008, vol. 57, no. 3, p. 584-93
Abstract OBJECTIVE: Glucagon-like peptide-1 (GLP-1) is a growth and differentiation factor for mature beta-cells and their precursors. However, the overall effect of GLP-1 on increasing beta-cell mass in both in vivo and in vitro conditions is relatively small, and augmenting this effect would be beneficial for the treatment or prevention of type 1 and type 2 diabetes. Here, we searched for cellular mechanisms that may limit the proliferative effect of GLP-1 and tested whether blocking them could increase beta-cell proliferation. RESEARCH DESIGN AND METHODS: We examined GLP-1-regulated genes in beta TC-Tet cells by cDNA microarrays. To assess the effect of some of these gene on cell proliferation, we reduced their expression using small heterogenous RNA in beta-cell lines and primary mouse islets and measured [(3)H]thymidine or 5'-bromo-2'-deoxyuridine incorporation. RESULTS: We identified four negative regulators of intracellular signaling that were rapidly and strongly activated by GLP-1: the regulator of G-protein-signaling RGS2; the cAMP response element-binding protein (CREB) antagonists cAMP response element modulator (CREM)-alpha and ICERI; and the dual specificity phosphatase DUSP14, a negative regulator of the mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase 1/2 (ERK1/2) pathway. We show that knockdown of CREMalpha or DUSP14 or expression of a dominant-negative form of DUSP14 increased beta-cell line proliferation and enhanced the GLP-1-induced proliferation of primary beta-cells. CONCLUSIONS: Together, our data show that 1) the cAMP/protein kinase A/CREB and MAPK/ERK1/2 pathways can additively control beta-cell proliferation, 2) beta-cells have evolved several mechanisms limiting GLP-1-induced cellular proliferation, and 3) blocking these mechanisms increases the positive effect of GLP-1 on beta-cell mass.
Keywords AnimalsCell LineCell Proliferation/drug effectsCells, CulturedCyclic AMP Response Element Modulator/genetics/metabolismDose-Response Relationship, DrugDual-Specificity Phosphatases/genetics/metabolismGene Expression ProfilingGene SilencingGlucagon-Like Peptide 1/pharmacologyGlucose/metabolism/pharmacologyHumansInsulin-Secreting Cells/cytology/drug effectsMaleMiceOligonucleotide Array Sequence AnalysisPeptides/pharmacologyRGS Proteins/genetics/metabolismVenoms/pharmacology
PMID: 18025410
Full text
Article (Author postprint) (563 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Supplemental data (296 Kb) - public document Free access
Other version: http://diabetes.diabetesjournals.org/content/57/3/584.long
Research group Fonction de l'îlot de Langerhans (324)
(ISO format)
KLINGER, Sonia et al. Increasing GLP-1-induced beta-cell proliferation by silencing the negative regulators of signaling cAMP response element modulator-alpha and DUSP14. In: Diabetes, 2008, vol. 57, n° 3, p. 584-93. https://archive-ouverte.unige.ch/unige:1825

193 hits



Deposited on : 2009-05-28

Export document
Format :
Citation style :